[Torasemide (Trifas) in clinical practice--own experience].
Torasemide (Trifas, Berlin Chemie/Menarini) is a loop diuretic and its site of action in the nephron is the afferent section of Henle's loop. Associated with this is its increased effectiveness and reduction of side effects in comparison with other loop diuretics like furosemide. Torasemide acts proportionately to the administered dose, which allows to asses its diuretic effect. It has been used in our Clinic in patients not responding to previous diuretic treatment. The diuretic effect of torasemide has been satisfactory, with no side effects. However, the trial group has not been numerous and was non-homogeneous in regard to renal failure and other disorders.
Grajewska
Magdalena
M
Katedra i Klinika Nefrologii i Chorób Wewnetrznych,  Akademia Medyczna w Bydgoszczy 85-094 Bydgoszcz, ul. M. Skłodowskiej-Curie 9.
Sulikowska
Beata
B
Manitius
Jacek
J
D058186:Acute Kidney Injury / Q000188:drug therapy; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004232:Diuretics / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006333:Heart Failure / Q000188:drug therapy; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D007676:Kidney Failure, Chronic / Q000188:drug therapy; D008297:Male; D013449:Sulfonamides / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000077786:Torsemide
D000959:Antihypertensive Agents; D004232:Diuretics; D013449:Sulfonamides; D000077786:Torsemide